Conduit Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 41 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings, up 6 from Q3 2024. 8 opened new positions and 2 sold out. The largest holders were Qube Research & Technologies Ltd ($145K), Rhumbline Advisers ($71K) and Barclays PLC ($61K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Cliff Asness (0.0% of AQR Capital Management's portfolio).
- Company
- Conduit Pharmaceuticals Inc.
- CUSIP
- 20678X106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $50K |
| Exits | 2 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 5,063,261 shares bought and 381,004 shares sold, net +4,682,257 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 41 holders
| Qube Research & Technologies Ltd | 0.00% | Add +561.7% | 2,106,548 | $145K |
| Rhumbline Advisers | 0.00% | Add +5034.0% | 1,028,702 | $71K |
| Barclays PLC | 0.00% | Add +6.5% | 892,350 | $61K |
| Geode Capital Management, LLC | 0.00% | Add +36.8% | 584,984 | $40K |
| BlackRock, Inc. | 0.00% | Reduce -28.6% | 539,736 | $37K |
| Citadel Advisors | 0.00% | Add +177.0% | 526,268 | $36K |
| Vanguard Group Inc. | 0.00% | Add +1.4% | 366,701 | $25K |
| Jane Street Group, LLC | 0.00% | New | 327,928 | $22K |
| Morgan Stanley | 0.00% | Add +42.5% | 261,508 | $18K |
| Goldman Sachs Group Inc. | 0.00% | Add +414.2% | 260,758 | $18K |
| Northern Trust Corp. | 0.00% | Add +0.7% | 186,178 | $13K |
| JPMorgan Chase & Co. | 0.00% | Add +706.2% | 176,365 | $12K |
| SG Americas Securities, LLC | 0.00% | Add +330.4% | 176,007 | $12K |
| FMR LLC | 0.00% | Add +740.4% | 170,901 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 167,968 | $12K |
| AQR Capital Management | 0.00% | Add +272.9% | 123,427 | $8K |
| Virtu Financial LLC | 0.00% | New | 123,714 | $8K |
| New York State Common Retirement Fund | 0.00% | No change | 88,700 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +132.7% | 86,457 | $6K |
| State Street Corp. | 0.00% | No change | 86,849 | $6K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +28.6% | 56,981 | $4K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 53,111 | $4K |
| Citigroup Inc. | 0.00% | Add +168.8% | 44,850 | $3K |
| Bank of America Corp. | 0.00% | Add +138.4% | 42,702 | $3K |
| Abel Hall, LLC | 0.00% | New | 40,023 | $3K |
| UBS Group AG | 0.00% | Reduce -82.4% | 29,721 | $2K |
| Wells Fargo & Company | 0.00% | Add +244.3% | 29,166 | $2K |
| Corebridge Financial, Inc. | 0.00% | Add +128.7% | 28,188 | $2K |
| Two Sigma Investments, LP | 0.00% | New | 27,909 | $2K |
| Susquehanna International Group, LLP | 0.00% | Add +37.6% | 25,014 | $2K |
| BNP Paribas Financial Markets | 0.00% | New | 16,427 | $1K |
| ProShare Advisors LLC | 0.00% | New | 15,966 | $1K |
| Invesco Ltd. | 0.00% | Add +19.7% | 12,880 | $883 |
| ADAR1 Capital Management, LLC | 0.00% | New | 11,200 | $768 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +13.0% | 9,640 | $661 |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 2,258 | $155 |
| California State Teachers Retirement System | 0.00% | No change | 1,670 | $115 |
| Sterling Capital Management LLC | 0.00% | No change | 44 | $3 |
| Amalgamated Bank | 0.00% | No change | 797 | $0 |
| Royal Bank of Canada | 0.00% | Add +30.2% | 3,517 | $0 |
| Cwm, LLC | 0.00% | Reduce -62.0% | 725 | $0 |
"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.